000			02199 a2200625 4500
005			20250517003519.0
264		0	_c20150720
008			201507s 0 0 eng d
022			_a1476-5586
024	7		_a10.1016/j.neo.2014.09.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aWiegering, Armin
245	0	0	_aE7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts. _h[electronic resource]
260			_bNeoplasia (New York, N.Y.) _cNov 2014
300			_a972-81 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCaco-2 Cells
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aColorectal Neoplasms _xgenetics
650	0	4	_aFemale
650	0	4	_aGene Expression _xdrug effects
650	0	4	_aHCT116 Cells
650	0	4	_aHT29 Cells
650	0	4	_aHuman Umbilical Vein Endothelial Cells _xdrug effects
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aKi-67 Antigen _xmetabolism
650	0	4	_aMice, Inbred Strains
650	0	4	_aMice, Nude
650	0	4	_aMutation
650	0	4	_aNeovascularization, Pathologic _xprevention & control
650	0	4	_aPhenylurea Compounds _xpharmacology
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aQuinolines _xpharmacology
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aTreatment Outcome
650	0	4	_aXenograft Model Antitumor Assays _xmethods
650	0	4	_aras Proteins _xgenetics
700	1		_aKorb, Doreen
700	1		_aThalheimer, Andreas
700	1		_aKämmerer, Ulrike
700	1		_aAllmanritter, Jan
700	1		_aMatthes, Niels
700	1		_aLinnebacher, Michael
700	1		_aSchlegel, Nicolas
700	1		_aKlein, Ingo
700	1		_aErgün, Süleyman
700	1		_aGermer, Christoph-Thomas
700	1		_aOtto, Christoph
773	0		_tNeoplasia (New York, N.Y.) _gvol. 16 _gno. 11 _gp. 972-81
856	4	0	_uhttps://doi.org/10.1016/j.neo.2014.09.008 _zAvailable from publisher's website
999			_c24381371 _d24381371